Lorox P Tablet contains a combination of Lornoxicam 8 mg and Paracetamol 325 mg, formulated to provide effective relief from pain and inflammation. Lornoxicam is a non-steroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol acts as an analgesic and antipyretic, providing additional pain relief and fever reduction through central inhibition of prostaglandin synthesis. This combination is particularly useful in managing acute musculoskeletal pain, osteoarthritis, rheumatoid arthritis, postoperative pain, and other inflammatory conditions where both analgesic and anti-inflammatory effects are desired. Lorox P Tablet offers rapid onset of action and improved efficacy compared to monotherapy with either agent alone. It should be used with caution in patients with a history of gastrointestinal ulcers, renal or hepatic impairment, and cardiovascular disease. Contraindications include hypersensitivity to either component and active gastrointestinal bleeding. The recommended dosage and duration should be strictly adhered to, and patients should be monitored for adverse effects such as gastrointestinal discomfort, renal dysfunction, or hypersensitivity reactions. Lorox P Tablet is intended for short-term use under medical supervision to ensure safety and optimal therapeutic outcomes.